Chemotherapy of brain tumors in aduts

Der Nervenarzt
P Roth, Michael Weller

Abstract

The treatment of patients with brain tumors has long been the domain of neurosurgery and radiotherapy but chemotherapy is now well established as an additional treatment option for many tumor entities in neuro-oncology. This is particularly true for patients with newly diagnosed and relapsing glioblastoma and anaplastic glioma as well as the treatment of medulloblastoma and primary lymphoma of the central nervous system (CNS). In addition to purely histopathological features, treatment decisions including those for chemotherapy are now based increasingly more on molecular tumor profiling. Within the group of gliomas these markers include the methylation status of the O-6-methylguanine-DNA methyltransferase (MGMT) promoter and the 1p/19q status, which reflects the loss of genetic material on chromosome arms 1p and 19q. The presence of a 1p/19q codeletion is associated with a better prognosis and increased sensitivity to alkylating chemotherapy in patients with anaplastic gliomas.

References

Aug 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E GalanisB W Scheithauer
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Sep 20, 2005·Lancet·M J van den BentUNKNOWN EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council
Feb 21, 2008·Journal of Surgical Oncology·Stephen R GrobmyerSteven N Hochwald
Apr 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy U LinEric P Winer
Sep 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Monika E HegiMark R Gilbert
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gigi ChenDerick Lau
Jul 10, 2009·The New England Journal of Medicine·Scott R PlotkinEmmanuelle di Tomaso
Nov 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Wolfgang WickMichael Weller
Jan 5, 2010·International Journal of Radiation Oncology, Biology, Physics·Ashley W JensenPaul D Brown
Oct 22, 2010·Current Opinion in Neurology·Patrick RothMichael Weller
Nov 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin KocherRolf-Peter Mueller
Apr 19, 2011·International Journal of Radiation Oncology, Biology, Physics·Paul W SperdutoMinesh Mehta
Jun 29, 2011·Annals of Neurology·Martin GlasUNKNOWN Neuro-Oncology Group of the German Cancer Society
Mar 30, 2012·The Lancet Oncology·Kim MargolinF Stephen Hodi
May 1, 2012·Journal of Neuro-oncology·Lakshmi NayakThomas J Kaley
May 15, 2012·The Lancet Oncology·Wolfgang WickUNKNOWN NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society
Sep 1, 2012·The Lancet Oncology·Michael WellerWolfgang Wick
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J van den BentKhê Hoang-Xuan
Oct 17, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory CairncrossMinesh Mehta
May 15, 2013·Nature Reviews. Neurology·Agnieszka Korfel, Uwe Schlegel
Jul 31, 2013·The Lancet Oncology·Michael WellerRoger Stupp
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark R GilbertMinesh P Mehta
Nov 6, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Oriana YuLaurent Azoulay
Feb 21, 2014·The New England Journal of Medicine·Mark R GilbertMinesh P Mehta
Feb 21, 2014·The New England Journal of Medicine·Olivier L ChinotTimothy Cloughesy
Feb 27, 2014·Nature Reviews. Clinical Oncology·Taofeek K OwonikokoJeffrey J Olson
Oct 15, 2014·Current Opinion in Neurology·Patrick Roth, Khê Hoang-Xuan
Feb 7, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael WellerUNKNOWN DIRECTOR Study Group
Feb 27, 2015·Neurology·Agnieszka KorfelMichael Weller

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.